ibritumomab tiuxetan
SpainDrugs containing this active substance
-
It is used to treat certain specific types of B-cell non-Hodgkin lymphoma (either in cases where other treatments have not worked or as consolidation treatment in patients with follicular lymphoma who have not received prior treatment).
Form: radiopharmaceutical preparation kit
Active substance Dosage ibritumomab tiuxetan 1,6 mg Manufacturer: Ceft Biopharma S.R.O.